Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Operating Margin (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Operating Margin for 15 consecutive years, with 6.2% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Margin rose 41.0% year-over-year to 6.2%, compared with a TTM value of 7.08% through Oct 2025, up 646.0%, and an annual FY2025 reading of 7.08%, up 646.0% over the prior year.
  • Operating Margin was 6.2% for Q4 2025 at Pharma-Bio Serv, up from 15.99% in the prior quarter.
  • Across five years, Operating Margin topped out at 10.06% in Q3 2023 and bottomed at 85.72% in Q4 2021.
  • Average Operating Margin over 5 years is 5.06%, with a median of 1.1% recorded in 2023.
  • The sharpest move saw Operating Margin crashed -8874bps in 2021, then soared 8936bps in 2022.
  • Year by year, Operating Margin stood at 85.72% in 2021, then skyrocketed by 104bps to 3.64% in 2022, then crashed by -139bps to 1.44% in 2023, then plummeted by -359bps to 6.61% in 2024, then grew by 6bps to 6.2% in 2025.
  • Business Quant data shows Operating Margin for PBSV at 6.2% in Q4 2025, 15.99% in Q3 2025, and 4.07% in Q2 2025.